Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.72 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAD52 | P43351 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL25347031 | 0.97 | ALOX15 (0.68) | ALOX15ACE2SIGMAR1SMN1; SMN2KDM4E | |
| SCHEMBL242967 | 0.85 | — | — | |
| SCHEMBL3975418 | 0.85 | ALOX15 (1.00) | ALOX15ACE2SIGMAR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL179843 | 0.85 | ALOX15 (1.00) | ALOX15ACE2SIGMAR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL1935309 | 0.84 | KEAP1 (0.54) | ALOX15ACE2SIGMAR1SMN1; SMN2GNAI3 | |
| SCHEMBL4396498 | 0.83 | ALOX15 (0.72) | ALOX15ACE2SIGMAR1ALDH1A1GNAI3 | |
| SCHEMBL856819 | 0.82 | SIGMAR1 (0.48) | ALOX15ACE2SIGMAR1SMN1; SMN2GNAI3 | |
| SCHEMBL11541738 | 0.82 | ALOX15 (0.93) | ALOX15ACE2SIGMAR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL11501587 | 0.82 | ALOX15 (0.93) | ALOX15ACE2SIGMAR1SMN1; SMN2KDM4E | |
| SCHEMBL6661360 | 0.82 | KDM1A (0.45) | ALOX15SIGMAR1SMN1; SMN2KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114878727-A | Method for determining hymexazol residues in tobacco | 合肥高尔生命健康科学研究院有限公司 | 2022-08-09 | — | — | CN | claimed |
| US-9476019-B2 | Cleaning agent for semiconductor provided with metal wiring | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2016-10-25 | — | — | US | claimed |
| US-20150259632-A1 | CLEANING AGENT FOR SEMICONDUCTOR PROVIDED WITH METAL WIRING | TRUIST BANK, AS NOTES COLLATERAL AGENT | 2015-09-17 | — | — | US | claimed |
| US-9045717-B2 | Cleaning agent for semiconductor provided with metal wiring | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2015-06-02 | — | — | US | claimed |
| WO-2013138278-A1 | COPPER CLEANING AND PROTECTION FORMULATIONS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2013-09-19 | — | — | WO | claimed |
| US-20130203643-A1 | CLEANING AGENT FOR SEMICONDUCTOR PROVIDED WITH METAL WIRING | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2013-08-08 | — | — | US | claimed |
| WO-2011094568-A2 | CLEANING AGENT FOR SEMICONDUCTOR PROVIDED WITH METAL WIRING | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2011-08-04 | — | — | WO | claimed |
| US-20250236621-A1 | 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES | ENLIVEN INC. | 2025-07-24 | — | — | US | disclosed |
| US-12240846-B2 | 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases | ENLIVEN INC. (US) | 2025-03-04 | — | — | US | disclosed |
| US-12162882-B2 | Quinolone derivatives as fibroblast growth factor receptor inhibitors | PRINCIPIA BIOPHARMAC, INC. (US) | 2024-12-10 | — | — | US | disclosed |
| CN-119019388-A | 5-And 6-azaindole compounds for inhibiting Bcr-Abl tyrosine kinase | 英莱汶公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-118063491-A | Imide catalyst auxiliary agent, polyimide film and preparation method | 中国科学院化学研究所 | 2024-05-24 | — | — | CN | disclosed |
| US-20240092777-A1 | Quinolone Derivatives as Fibroblast Growth Factor Receptor Inhibitors | PRINCIPIA BIOPHARMA INC. (US) | 2024-03-21 | — | — | US | disclosed |
| US-6015814-A | Quinazoline derivative | ZENECA LIMITED (GB) | 2000-01-18 | — | — | US | disclosed |
| US-5814634-A | PEPTIC ULCERS, GASTRIC ULCERS | SHISEIDO CO. LTD. (JP) | 1998-09-29 | — | — | US | disclosed |
| EP-0824526-A1 | QUINAZOLINE DERIVATIVE | ZENECA LIMITED (GB) | 1998-02-25 | — | — | EP | disclosed |
| EP-0802196-A1 | Alkylenediamine derivative, antiulcer drug, and antibacterial drug | SHISEIDO COMPANY LIMITED (JP) | 1997-10-22 | — | — | EP | disclosed |
| WO-1996033978-A1 | QUINAZOLINE DERIVATIVE | ZENECA LIMITED (GB) | 1996-10-31 | — | — | WO | disclosed |
| US-4992150-A | Telomer with alpha-olefin;oil and fuel additive | NIPPON OIL CO, LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
| US-4069064-A | Phthalocyanine formulations having high gloss, which are stabilized against recrystallization and against change of modification | BASF AKTIENGESELLSCHAFT (DT) | 1978-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12162882-B2 | Quinolone derivatives as fibroblast growth factor receptor inhibitors | FGFR1, FGFR3, FGFR2 | ALOX15 2591/4885ACE2 2037/4885SIGMAR1 4534/4885 |
| US-20250236621-A1 | 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES | ABL1, ABL2, BCR | ALOX15 3664/4885ACE2 3549/4885SIGMAR1 3797/4885 |
| US-20240092777-A1 | Quinolone Derivatives as Fibroblast Growth Factor Receptor Inhibitors | FGFR1, FGFR3, FGFR2 | ALOX15 2591/4885ACE2 2037/4885SIGMAR1 4534/4885 |
| US-12240846-B2 | 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases | ABL1, ABL2, BCR | ALOX15 3664/4885ACE2 3549/4885SIGMAR1 3797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.